-

12:48:05 PM

BDX Stock News

BDX - Becton Dickinson & Co.

09/26/23 8:00 AM

Nasdaq, NYSE : AZTA, BDX

Azenta Announces CFO Transition

Azenta, Inc. today announced that Herman Cueto will join Azenta as Executive Vice President and Chief Financial Officer, effective October 16.

RHEA-AI

neutral

09/19/23 11:25 AM

NYSE : BDX

BD Ranks in Top 10 for Transparency, Awarded Best Code of Conduct in 2023 U.S. Transparency Awards

BD, a leading global medical technology company, today announced it has been ranked in the top 10 for overall transparency and awarded Best Code of Conduct among S&P 250 companies in the fifth annual U.S. Transparency Awards by Labrador, a global communications firm specializing in corporate disclosures.

RHEA-AI

very positive

09/07/23 8:00 AM

NYSE : BDX

Navigate BioPharma Services, Inc. Announces Collaboration with BD (Becton, Dickinson and Company) to Advance Capabilities for Clinical Phases of Drug Development

Navigate BioPharma Services, Inc., a specialty laboratory offering high-quality, innovative precision medicine solutions and bioanalytics for clinical development and diagnostic applications, announces a strategic collaboration with BD, a leading global medical technology company, to explore opportunities to...

RHEA-AI

positive

08/23/23 4:15 PM

NYSE : BDX

conferences

BD to Present at Investor Healthcare Conferences

BD, a leading global medical technology company, today announced that it will present at the following healthcare conferences:. 2023 Wells Fargo Healthcare Conference September 6, 2023 8:45 a.m. EDT. Morgan Stanley 21 st Annual Global Healthcare Conference September 12, 2023 8:50 a.m. EDT.

RHEA-AI

positive

08/03/23 6:30 AM

NYSE : BDX

earnings

BD Reports Third Quarter Fiscal 2023 Financial Results

Revenue of $4.9 billion increased 5.1% as reported and 6.3% on a currency-neutral basis Revenue from base business grew 6.7% as reported, 7.9% currency-neutral or 6.3% organic GAAP and adjusted diluted EPS from continuing operations of $1.36 and $2.96, respectively Company raises full-year base organic revenue growth guidance; maintains full-year...

RHEA-AI

neutral

08/01/23 6:50 AM

NYSE : BDX

covid-19

BD Receives 510(k) Clearance for COVID-19, Influenza A/B, RSV Molecular Combination Test

BD, a leading global medical technology company, today announced U.S. Food and Drug Administration 510 clearance for the BD Respiratory Viral Panel for BD MAX™ System, a single molecular diagnostic...

RHEA-AI

neutral

07/25/23 4:15 PM

NYSE : BDX

dividends

BD Board Declares Dividend

The Board of Directors of BD has declared a quarterly dividend of $0.91 per common share, payable on September 29, 2023 to holders of record on September 8, 2023. The indicated annual dividend rate is $3.64 per share. About BD BD is one of the largest global medical technology companies in the world and is advancing the...

RHEA-AI

positive

07/24/23 4:15 PM

NYSE : BDX

management

BD Names Joanne Waldstreicher to Board of Directors

BD, a leading global medical technology company, today announced the appointment of Dr. Joanne Waldstreicher to its board of directors. Waldstreicher, 63, was most recently the chief medical officer for Johnson& Johnson, serving in this capacity from 2012 until her retirement in 2023.

RHEA-AI

very positive

07/24/23 6:50 AM

NYSE : BDX

clinical trial

BD CEO Tom Polen Addresses FDA 510(k) Clearance of BD Alaris™ Infusion System

BD Chairman, CEO and President Tom Polen issued the following message regarding the U.S. Food and Drug Administration 510 clearance for the updated BD Alaris™ Infusion System:. "Hello, I'm Tom Polen, chairman, CEO and president of BD. I wanted to share some exciting news and explain what it means for our company and our...

RHEA-AI

positive

07/21/23 4:30 PM

NYSE : BDX

clinical trial

BD Receives FDA 510(k) Clearance for Updated BD Alaris™ Infusion System

BD Alaris™ Infusion System is the only modular and most comprehensive infusion system on the U.S. market that includes large volume pumps, syringe pumps, patient-controlled analgesia pumps, respiratory monitoring, auto-identification, dose error reduction software and EMR interoperability BD Alaris™ Infusion System's unique "One System" platform...

RHEA-AI

positive

1 2 3 4 5 6 7 8 9 10 Next